Related Experiment Videos

Verapamil: an effective calcium blocking agent for pediatric patients

Pediatrics
|May 1, 1983
PubMed

Insights

Verapamil, a calcium channel blocker, effectively treats cardiac dysrhythmias like supraventricular tachycardia and atrial flutter in all ages. Pediatricians should understand its pediatric uses and potential hazards.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Verapamil is a recently FDA-approved slow-channel calcium-blocking agent.
  • It is indicated for cardiac dysrhythmias across all age groups.

Purpose of the Study:

  • To inform pediatricians about verapamil's use in children.
  • To detail verapamil's indications, contraindications, adverse reactions, administration, and overdose treatment.

Main Methods:

  • Review of verapamil's pharmacological actions.
  • Analysis of clinical investigations and potential therapeutic uses.

Main Results:

  • Verapamil slows atrioventricular node conduction, treating supraventricular tachycardia and atrial flutter.
  • It may relieve left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy.

Conclusions:

  • Verapamil is a valuable therapeutic option for various cardiac conditions.
  • Awareness of its pediatric applications and safety profile is crucial for healthcare providers.

Related Concept Videos